Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative

COVID‐19 is disastrous to global health and the economy. SARS‐CoV‐2 infection exhibits similar clinical symptoms and immunopathological sequelae to SARS‐CoV infection. Therefore, much of the developmental progress on SARS‐CoV vaccines can be utilized for the development of SARS‐CoV‐2 vaccines. Caref...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalash, Ahmed O., Hussein, Waleed M., Skwarczynski, Mariusz, Toth, Istvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373118/
https://www.ncbi.nlm.nih.gov/pubmed/34176237
http://dx.doi.org/10.1002/advs.202100985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373118/
https://www.ncbi.nlm.nih.gov/pubmed/34176237
http://dx.doi.org/10.1002/advs.202100985

Ejemplares similares